No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
No analyst estimates.
5 funds hold a position.
Top-trader positions in SRXH could not be loaded.
Hyperliquid positioning - not every stock is covered
Last report
Aug 13, 2026
Period ending
Jun 30, 2026
Earnings per share
EPS comparison unavailable
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / income | Surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 13, 2026 | Unavailable | - | $3.4M No estimateSEC filing | Unavailable |
| Mar 31, 2026 | May 14, 2026 | Unavailable | - | $3.4M No estimateSEC filing | Unavailable |
| Dec 31, 2025 | Feb 13, 2026 | Unavailable | - | $2.8M No estimateSEC filing | Unavailable |
| Jun 30, 2025 | Sep 30, 2025 | Unavailable | - | $2.7M No estimateSEC filing | Unavailable |
| Mar 31, 2025 | May 15, 2025 | Unavailable | - | $7.2M No estimateSEC filing | Unavailable |
| Dec 31, 2024 | Mar 31, 2025 | -$0.56 / -$0.10Alpha Vantage | -$0.46 miss | $35.0M No estimateYear ended Dec 31, 2024 · SEC filing | Unavailable |
| Sep 30, 2024 | Nov 13, 2024 | Unavailable | - | $11.4M No estimateSEC filing | Unavailable |
| Jun 30, 2024 | Aug 14, 2024 | Unavailable | - | $42.7M No estimateSEC filing | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue and income use company releases, SEC filings, Alpha Vantage or Yahoo Finance. Non-USD revenue carries its currency code. Comparisons require a paired release estimate.
Fairly priced and running thin margins.
Valuation
Quality
Growth
This stock is under pressure, and looks oversold after a sharp drop.
Trend
Under pressure
25 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace